SEC Form 4 · accession 0001127430-17-000017
INSMED Inc · INSM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew T Drechsler
Officer — Chief Financial Officer
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001104506
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | M | 20,000 | $6.65 | A | 25,000 | D | |
| Common StockF1 | Mar 1, 2017 | S | 20,000 | $16.51 | D | 5,000 | D | |
| Common Stock | Mar 1, 2017 | M | 10,000 | $6.65 | A | 15,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $6.65 | Mar 1, 2017 | M | 20,000 | D | — | Nov 7, 2022 | Common Stock | 20,000 | 74,855 | D |
| Stock Option (right to buy)F2 | $6.65 | Mar 1, 2017 | M | 10,000 | D | — | Nov 7, 2022 | Common Stock | 10,000 | 45,145 | D |
Explanation of responses
- F1The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.46 to $16.74, inclusive.
- F2Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.